Category: Oncology/Hematology
United States Oncology/Hematology
-
2024 United States Cancer Biomarkers Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
United States Veterinary Oncology Market By Animal Type (Canine, Feline, Equine), By Therapy (Radiotherapy, Surgery, Chemotherapy, Immunotherapy and Other Therapies), By Cancer Type (Skin Cancers, Lymphomas, Sarcomas and Others), By Region, Competition, Forecast & Opportunities, 2019-2029F
... 2019-2029F United States Veterinary Oncology Market was valued at USD 450.63 Million in 2023 and is expected to reach USD 644.03 Million by 2029 with a CAGR of 6.09% during the forecast period. The United ... Read More
-
United States Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Diabetology, Respiratory, Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F
... Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F United States generic drugs market is projected to witness a CAGR of 6.68% during the forecast period 2024-2031, growing ... Read More
-
2024 US Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
... pages and 50 tables. The report presents a comprehensive analysis of the US hospital cancer diagnostics market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and ... Read More
-
Multiple Myeloma Therapeutics
... by 2030, growing at a CAGR of 14.6% over the analysis period 2023-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$37.6 ... Read More
-
US Esoteric Testing Market Size study, by Type (Oncology testing, Infectious disease testing, Genetic testing, Endocrinology testing, Toxicology testing, Neurology testing, Others), By Technology (Chemiluminescence immunoassay, Enzyme-linked immunosorbent assay, Mass spectrometry, Real time polymerase chain reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) Forecasts 2022-2032
... reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) Forecasts 2022-2032 US Esoteric Testing Market is valued approximately USD 6.87 Billion in 2023 and is anticipated to grow with a ... Read More
-
2024 North America Nucleic Acid Testing (NAT) Market Opportunities in the US, Canada, Mexico - Competitive Shares and Growth Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests - Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks
... - Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is designed to help current suppliers and ... Read More
-
2024 U.S. Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers and R
... is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products for diagnosing genetic diseases, cancer, as well as forensic and paternity/HLA testing during the ... Read More
-
2024 U.S. Molecular Diagnostics Market: 2023 Supplier Shares, Instrumentation Installed Base and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... supplier shares, the 2023-2028 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing new technologies and products for ... Read More
-
2024 North America Molecular Diagnostics Market in the US, Canada, Mexico - 2023 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic a
... Paternity Tests This database from LeadingMarketResearch.com provides the 2023 supplier shares, the 2023-2028 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of ... Read More
-
2024 North America Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostics Market—Growth Opportunities in the US, Canada, Mexico - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Instrumentation Pipeline,
... Barriers and Risks This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products for diagnosing genetic diseases, cancer, as well as ... Read More
-
US Laboratory Developed Tests Market Size study, by Technology Outlook (Immunoassays, Hematology & Coagulation, Molecular Diagnostics, Microbiology, Clinical Chemistry, Histology/Cytology, Others), by Application Outlook (Oncology, Genetic Disorders/Inherited Disease, Infectious & Parasitic Diseases, Other Diseases) and Regional Forecasts 2022-2032.
... Regional Forecasts 2022-2032. US Laboratory Developed Tests Market is valued at approximately USD 3.47 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.20% over the forecast period ... Read More
-
2024 North America Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - US, Canada, Mexico - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new 3-country report from LeadingMarketResearch.com.This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and ... Read More
-
Prostate Cancer Diagnostics
... by 2030, growing at a CAGR of 13.1% over the period 2023-2030. Preliminary Test, one of the segments analyzed in the report, is expected to record 12.4% CAGR and reach US$10 Billion by the end ... Read More
-
United States Liquid Biopsy Market Report by Cancer types (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, and Other Cancer), Products (Kits & Reagents, Platforms & Instruments, and Services), Application (Early Diagnosis, Patient Monitoring, and Recurrence Monitoring), Biomarkers (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Extracellular Vesicles (EVs), and Other Biomarker Types), Sample types (Blood, Urine, and Others), End-Users (Hospitals & Laboratories and Governments & Academic Research Centers), and Company Analysis 2024-2032
... Monitoring, and Recurrence Monitoring), Biomarkers (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Extracellular Vesicles (EVs), and Other Biomarker Types), Sample types (Blood, Urine, and Others), End-Users (Hospitals & Laboratories and Governments & Academic Research ... Read More
-
2023 North America Hematology Market Shares in the US, Canada and Mexico - Competitive Analysis of Leading and Emerging Market Players
... analyses current and emerging suppliers of hematology analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include: ... Read More
-
U.S. Cancer Contrast Media Market Size - By Product Type (Gadolinium-based Contrast Media, Iodinated Contrast Media), Modality (Nuclear Imaging, CT, MRI, Mammography), Application (Breast Cancer, Bladder Cancer, Lung Cancer), End-use & Forecast, 2024 - 2032
... U.S. Cancer Contrast Media Market size is poised to expand at 4.9% CAGR between 2024 and 2032 driven by the continuous technological advancements in imaging and the launch of new products. Innovations in MRI and ... Read More
-
US Generic Drug Market Report by Segment (Unbranded, Branded), Therapy Area (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) 2024-2032
... US generic drug market size reached US$ 90.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 124.3 Billion by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032. The ... Read More
-
2024 Global Clinical Chemistry and Immunodiagnostics Market in the US, Europe, Japan - 2023 Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Te
... TDM Tests This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), ... Read More
-
2024 North America Clinical Chemistry and Immunodiagnostics Market in the US, Canada and Mexico - 2023 Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein
... Immunoprotein and TDM Tests This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, ... Read More
-
Oncologists Global Market Opportunities And Strategies To 2032 Including: 1) By Cancer Diagnosis And Treatment: Cancer Diagnosis; Cancer Treatment 2) By Indication: Lungs Cancer; Colorectal Cancer; Breast Cancer; Liver Cancer; Bladder Cancer; Head And Neck Cancer; Prostate Cancer 3) By Service Provider: Hospitals; Diagnostic Laboratories; Diagnostic Imaging Centers; Specialty Clinics; Academia Covering: Kaiser Foundation Health Plan, Inc.; HCA Healthcare, Inc.; The University of Texas MD Anderson Cancer Center; Tenet Healthcare Corporation; Universal Health Services, Inc.
... Cancer3) By Service Provider: Hospitals; Diagnostic Laboratories; Diagnostic Imaging Centers; Specialty Clinics; AcademiaCovering: Kaiser Foundation Health Plan, Inc.; HCA Healthcare, Inc.; The University of Texas MD Anderson Cancer Center; Tenet Healthcare Corporation; Universal Health Services, ... Read More
-
NA Acute Myeloid Leukemia Diagnostics Market - Industry Trends and Forecast to 2035
... to 2031. The new market report contains data for the historic year 2022, the base year of calculation is 2023, and the forecast period is 2024 to 2031. Market Segmentation North America Acute Myeloid Leukemia ... Read More
-
U.S. Prostate Cancer Nuclear Medicine Diagnostics Market Size, Share & Trends Analysis Report By Type (SPECT, PET), By PET Product (F-18, SR-82/RB-82), And Segment Forecasts, 2023 - 2030
... Growth & Trends The U.S. prostate cancer nuclear medicine diagnostics market size is expected to reach USD 153.97 million by 2030, according to a new report by Grand View Research, Inc. It is anticipated to ... Read More
-
US Acute Myeloid Leukemia Market to 2028
... in Research and Development, and a constant growth in population. Advancement in therapeutic approaches, including targeted therapies, immunotherapies, checkpoint inhibitors, and personalized medicines, have revolutionized AML treatment, boosting patient satisfaction and reducing side effects. Rising ... Read More
-
US Kidney Cancer Therapeutics and Diagnostics Market to 2028
... increase in success rate of targeted therapies, expansion of hospitals and NCI- funded cancer centers, and constant growth in population. Advancement in therapeutic approaches, including targeted therapies, immunotherapies, checkpoint inhibitors, and personalized medicines, have revolutionized ... Read More
Research Assistance
